Abu-Abed, S. S., Beckett, B. R., Chiba, H., Chithalen, J. V., Jones, G., Metzger, D., Chambon, P. and Petkovich, M (1998). Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha. J. Biol. Chem 273, 2409-2415.[Abstract/Free Full Text]
Adra, C. N., Boer, P. H. and McBurney, M. W (1987). Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 60, 65-74.[Medline]
Becker, S., Wang, Z. J., Massey, H., Arauz, A., Labosky, P., Hammerschmidt, M., St-Jacques, B., Bumcrot, D., McMahon, A. and Grabel, L (1997). A role for Indian hedgehog in extraembryonic endoderm differentiation in F9 cells and the early mouse embryo. Dev. Biol 187, 298-310.[Medline]
Benoit, G., Altucci, L., Flexor, M., Ruchaud, S., Lillehaug, J. Raffelsberger, W., Gronemeyer, H. and Lanotte, M (1999). RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J 18, 7011-7018.[Medline]
Bouillet, P., Oulad-Abdelghani, M., Vicaire, S., Garnier, J. M., Schuhbaur, B., Dolle, P. and Chambon, P (1995). Efficient cloning of cDNAs of retinoic acid-responsive genes in P19 embryonal carcinoma cells and characterization of a novel mouse gene, Stra1 (mouse LERK-2/Eplg2). Dev. Biol 170, 420-433.[Medline]
Boylan, J. F., Lohnes, D., Taneja, R., Chambon, P. and Gudas, L. J (1993). Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc. Nat. Acad. Sci. USA 90, 9601-9605.[Abstract/Free Full Text]
Boylan, J. F., Lufkin, T., Achkar, C. C., Taneja, R., Chambon, P. and Gudas, L. J (1995). Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell Biol 15, 843-851.[Abstract]
Brocard, J., Kastner, P. and Chambon, P (1996). Two novel RXR alpha isoforms from mouse testis. Biochem. Biophys. Res. Commun 229, 211-218.[Medline]
Cavailles, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P. J. and Parker, M. G (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14, 3741-3751.[Medline]
Chambon, P (1994). The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol 5, 115-125.[Medline]
Chambon, P (1996). A decade of molecular biology ot retinoic acid receptors. FASEB. J 10, 940-954.[Abstract]
Chiba, H., Clifford, J., Metzger, D. and Chambon, P (1997). Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells. J. Cell Biol 139, 735-747.[Abstract/Free Full Text]
Chiba, H., Clifford, J., Metzger, D. and Chambon, P (1997). Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Mol. Cell Biol 17, 3013-3020.[Abstract]
Clifford, J., Chiba, H., Sobieszczuk, D., Metzger, D. and Chambon, P (1996). RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J 15, 4142-4155.[Medline]
Costa, S. L. and Mc Burney, M. W (1996). Dominant negative mutant of retinoic acid receptor alpha inhibits retinoic acid-induced P19 cell differentiation by binding to DNA. Exp. Cell Res 225, 35-43.[Medline]
Damm, K. R., Heyman, R., Umezono, K. and Evans, R. M (1993). Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Nat. Acad. Sci. USA 90, 2989-2993.[Abstract/Free Full Text]
Dittman, W. A., Kumada, T., Sadler, J. E. and Majerus, P. W (1988). The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells. J. Biol. Chem 263, 15815-15822.[Abstract/Free Full Text]
Dittman, W. A., Nelson, S. C., Greer, P. K., Horton, E. T., Palomba, M. L. and McCachren, S. S (1994). Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acidresponse element in the human thrombomodulin gene. J. Biol. Chem 269, 16925-16932.[Abstract/Free Full Text]
Durand, B., Saunders, M., Gaudon, C., Roy, B., Losson, R. and Chambon, P (1994). Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 13, 5370-5382.[Medline]
Folkers, G. E., van Heerde, E. C. and van der Saag, P. T (1995). Activation function 1 of retinoic acid receptor beta 2 is an acidic activator resembling VP16. J. Biol. Chem 270, 23552-23559.[Abstract/Free Full Text]
Fujii, H., Sato, T., Kaneko, S., Gotoh, O., Fujii-Kuriyama, Y., Osawa, K., Kato, S. and Hamada, H (1997). Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. EMBO J 16, 4163-4173.[Medline]
Gaub, M. P., Rochette-Egly, C., Lutz, Y., Ali, S., Matthes, H., Scheuer, I. and Chambon, P (1992). Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp. Cell Res 201, 335-346.[Medline]
Ghyselinck, N. B., Dupe, V., Dierich, A., Messaddeq, N., Garnier, J. M., Rochette-Egly, C., Chambon, P. and Mark, M (1997). Role of the retinoic acid receptor beta (RARbeta) during mouse development. Int. J. Dev. Biol 41, 425-447.[Medline]
Gronemeyer, H. and Laudet, V (1995). Transcription factors 3: nuclear receptors. Protein Profile 2, 1173-1308.[Medline]
Gudas, L. J (1994). Retinoids and vertebrate development. J. Biol. Chem 269, 15399-15402.[Abstract/Free Full Text]
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. and Pease, L. R (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.[Medline]
Kastner, P., Mark, M. and Chambon, P (1995). Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?. Cell 83, 859-869.[Medline]
Kastner, P., Mark, M., Ghyselinck, N., Krezel, W., Dupe, V., Grondona, J. M. and Chambon, P (1997). Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124, 313-326.[Abstract]
Krowczynska, A. M., Coutts, M., Makrides, S. and Brawerman, G (1989). The mouse homologue of the human acidic ribosomal phosphoprotein PO: a highly conserved polypeptide that is under translational control. Nucl. Acids Res 17, 6408-.[Free Full Text]
Kruyt, F. A., van der Veer, L. J., Mader, S., van den Brink, C. E., Feijen, A., Jonk, L. J., Kruijer, W. and van der Saag, P. T (1992). Retinoic acid resistance of the variant embryonal carcinoma cell line RAC65 is caused by expression of a truncated RAR alpha. Differentiation 49, 27-37.[Medline]
Le Douarin, B., Zechel, C., Garnier, J. M., Lutz, Y., Tora, L., Pierrat, P., Heery, D., Gronemeyer, H., Chambon, P. and Losson, R (1995). The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14, 2020-2033.[Medline]
Leid, M., Kastner, P. and Chambon, P (1992). Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci 17, 427-433.[Medline]
Mangelsdorf, D. J. and Evans, R. M (1995). The RXR heterodimers and orphan receptors. Cell 83, 841-850.[Medline]
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. et al (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.[Medline]
Mascrez, B., Mark, M., Dierich, A., Ghyselinck, N. B., Kastner, P. and Chambon, P (1998). The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. Development 125, 4691-4707.[Abstract]
Meyer, M. E., Gronemeyer, H., Turcotte, B., Bocquel, M. T., Tasset, D. and Chambon, P (1989). Steroid Hormone receptors compete for factors that mediate their enhancer function. Cell 57, 433-442.[Medline]
Moras, D. and Gronemeyer, H (1998). The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol 10, 384-391.[Medline]
Nagpal, S., Saunders, M., Kastner, P., Durand, B., Nakshatri, H. and Chambon, P (1992). Promoter context-and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70, 1007-1019.[Medline]
Nagpal, S., Friant, S., Nakshatri, H. and Chambon, P (1993). RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J 12, 2349-2360.[Medline]
Niforas, P., Chu, M. D. and Bird, P (1996). A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells. Gene 176, 139-147.[Medline]
Pahl, H. L. and Baeuerle, P. A (1999). Control of gene expression by proteolysis. Curr. Opin. Cell Biol 8, 340-347.
Pratt, M. A., Kralova, J. and McBurney, M. W (1990). A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol. Cell Biol 10, 6445-6453.[Abstract/Free Full Text]
Renaud, J. P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H. and Moras, D (1995). Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.[Medline]
Rochette-Egly, C., Lutz, Y., Saunders, M., Scheuer, I., Gaub, M. P. and Chambon, P (1991). Retinoic acid receptor gamma: specific immunodetection and phosphorylation. J. Cell Biol 115, 535-545.[Abstract/Free Full Text]
Schulman, I. G., Juguilon, H. and Evans, R. M (1996). Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell Biol 16, 3807-3813.[Abstract]
Strickland, S. and Mahdavi, V (1978). The induction of differentiation in teratocarcinoma cells by retinoic acid. Cell 15, 393-403.[Medline]
Strickland, S., Smith, K. K. and Marotti, K. R (1980). Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21, 347-355.[Medline]
Taneja, R., Bouillet, P., Boylan, J. F., Gaub, M. P., Roy, B., Gudas, L. J. and Chambon, P (1995). Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc. Nat. Acad. Sci. USA 92, 7854-7858.[Abstract/Free Full Text]
Taneja, R., Roy, B., Plassat, J. L., Zusi, C. F., Ostrowski, J., Reczek, P. R. and Chambon, P (1996). Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Nat. Acad. Sci. USA 93, 6197-6202.[Abstract/Free Full Text]
Taneja, R., Rochette-Egly, C., Plassat, J. L., Penna, L., Gaub, M. P. and Chambon, P (1997). Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J 16, 6452-6465.[Medline]
Tasset, D., Tora, L., Fromental, C., Scheer, E. and Chambon, P (1990). Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62, 1177-1187.[Medline]
Valentini, R. P., Brookhiser, WT., Park, J., Yang, T., Briggs, J., Dressler,G. and Holzman, L. B (1997). Post-translational processing and renal expression of mouse Indian Hedgehog. J. Biol. Chem 272, 8466-8473.[Abstract/Free Full Text]
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P. and Gronemeyer, H (1996). TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15, 3667-3675.[Medline]
vom Baur, E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P. and Losson, R (1996). Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15, 110-124.[Medline]
Wan, Y. J., Wang, L. and Wu, T. C (1994). The expression of retinoid X receptor genes is regulated by all-trans-and 9-cis-retinoic acid in F9 teratocarcinoma cells. Exp. Cell Res 210, 56-61.[Medline]
Wurtz, J. M., Bourguet, W., Renaud, J. P., Vivat, V., Chambon, P., Moras, D. and Gronemeyer, H (1996). A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol 3, 206-.[Medline]
Xu, L., Glass, C. K. and Rosenfeld, M. G (1999). Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev 9, 140-147.[Medline]
Zelent, A., Krust, A., Petkovich, M., Kastner, P. and Chambon, P (1989). Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin. Nature 339, 714-717.[Medline]
